Intract Pharma Information

Intract Pharma is a biotechnology company innovating in the field of oral delivery of complex proteins such as monoclonal antibodies with a special focus on treatment of gastrointestinal and systemic immune-mediated inflammatory diseases. Intract is applying it’s Phloral™ and Soteria™ technology platform for precision delivery of proteins to the colon for local tissue and systemic immunomodulation. Our vision is to transform care for millions of patients suffering from chronic diseases by converting their potent injectable biologic medicines into safe, effective and convenient take-at-home pills.

Website	https://www.intractpharma.com
Revenue	$5.9 million
Employees	14 (5 on RocketReach)
Founded	2016
Address	2 Royal College Street, London, England NW1 0NH, GB
Phone	+44 20 7691 4918
Technologies	Microsoft Outlook , Microsoft Exchange Online , Cloudflare DNS +1 more (view full list)
Industry	Biotechnology Research, Manufacturing General, Life Science, Manufacturing, Biotechnology, Science and Engineering, Pharmaceutical, Health Care
Web Rank	27 Million
Keywords	Drug Delivery, Monoclonal Antibodies, Biotechnology, Protein Therapeutics, Therapeutic Proteins, Pharmaceutical, Inflammatory Diseases, Drug Development, Immunology, Gastrointestinal Diseases, Biologics, Therapeutics, Biopharma, Treatment, Clinical Trials, New Drug Applications
Competitors	Pfizer, Sanofi, AstraZeneca, Amgen, Vaxart, Inc., BioXcel Therapeutics, Inc., Lilly India, CureMetrix, Theramatrix Physical Therapy Network, Inc, DiogenX +49 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies
NAICS	NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies